This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Named after a part of the eye responsible for central, sharper vision, start-up biotech Fovea Pharmaceuticals SA (developing treatments for retinal diseases) received €20.5mm ($25mm) in Series A investments from Sofinnova Partners, Abingworth Management, Wellcome Trust, GIMV, and Credit Agricole Private Equity. Sofinnova, which seeded the company in May 2005, led the round.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?